Zobrazeno 1 - 10
of 23
pro vyhledávání: '"KEN-ICHI SAKO"'
Autor:
Tomoko Mizaki, Hironobu Nobata, Shogo Banno, Makoto Yamaguchi, Hiroshi Kinashi, Shiho Iwagaitsu, Takuji Ishimoto, Yukiko Kuru, Masafumi Ohnishi, Ken-ichi Sako, Yasuhiko Ito
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-13 (2023)
Abstract Background Mycophenolate mofetil (MMF), a prodrug of the immunosuppressive agent mycophenolic acid (MPA), is difficult to administer because of the pharmacokinetic complexity of MPA. Although dosage adjustment according to the 12-h area unde
Externí odkaz:
https://doaj.org/article/5227606631284128b5d5a90de015bf1c
Autor:
Toshiyuki Yamada, Aya Ando, Ryusuke Morita, Ken-Ichi Sako, Shigeki Tsuchida, Hiroyuki Yamamoto
Publikováno v:
Reproduction; Dec2024, Vol. 168 Issue 6, p36-44, 9p
Publikováno v:
In Vivo; May/Jun2024, Vol. 38 Issue 3, p1436-1442, 7p, 2 Charts, 2 Graphs
Autor:
Takeshi, Chiba, Haruki, Ujiie, Yukiko, Yaegashi, Kengo, Umehara, Shinya, Takada, Koichi, Otaki, Ken-Ichi, Sako, Yuta, Nakamaru, Tomoji, Meada, Kenzo, Kudo, Yoshikazu, Tasaki, Hideki, Sato
Publikováno v:
Biomedical Reports. 17
This study aimed to investigate whether renin-angiotensin system inhibitors (RAS-I) have an advantage over calcium channel blockers (CCB) for suppression of proteinuria in hypertensive patients with gastric cancer receiving ramucirumab (RAM) treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfcd25dffcff4115e6d0f882c9d8ef45
https://doi.org/10.3892/br.2022.1559
https://doi.org/10.3892/br.2022.1559
The coronavirus disease 2019 (COVID-19) pandemic and its persistence have created a need for effective treatments. Patients with COVID-19 have been treated with a combinatorial therapy comprising lopinavir and ritonavir (LPV/r), which is used to trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4e5dae2785ac99a8213fe3416755acc
https://doi.org/10.21203/rs.3.rs-1467208/v1
https://doi.org/10.21203/rs.3.rs-1467208/v1
Autor:
Shigekazu Watanabe, Miki Yajima, Haruna Matsumoto, Yoshihiko Matsuki, Tamaki Watanabe, Ken-ichi Sako
Publikováno v:
Japanese Journal of Infection Prevention and Control. 35:223-232
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f69d4ea10e4dcb5949dad0ed201ae14
https://doi.org/10.4058/jsei.35.223
https://doi.org/10.4058/jsei.35.223
Autor:
Hiroyuki Kato, Takako Osawa, Yuki Usui, Manabu Tanaka, Ken Ichi Sako, Kaoru Aoki, Takumi Okihara, Naoyuki Nishimura, Kazutaka Miyamae, Hisao Haniu, Shigeaki Moriyama, Atsushi Sobajima, Naoto Saito
Publikováno v:
ACS Biomaterials Science & Engineering. 6:7032-7040
Because ultrahigh-molecular-weight polyethylene (UHMWPE) is susceptible to frictional wear when used in sliding members of artificial joints, it is common practice to use cross-linked UHMWPE instead. However, cross-linked UHMWPE has low impact resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40db84bde885a388e3e43487c0b4b16d
https://doi.org/10.1021/acsbiomaterials.0c00916
https://doi.org/10.1021/acsbiomaterials.0c00916
Autor:
Ken-ichi Sako, Mamoru Kyogashima, Shiro Nakahara, Kota Yamada, Akihito Kudo, Tetsuya Ishikawa, Isao Taguchi, Teruo Inoue, Hidehiko Nakamura
Publikováno v:
SN Comprehensive Clinical Medicine. 2:893-898
Sulfatides might accelerate atherothrombosis. Therefore, this study aimed to monitor serum sulfatide levels in coronary arteries across atheromatous plaques during percutaneous coronary intervention (PCI) with either drug-eluting stents or drug-coate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68a44c3ed5a74648ecfe0d0553d84d82
https://doi.org/10.1007/s42399-020-00318-9
https://doi.org/10.1007/s42399-020-00318-9
Autor:
Tamaki Watanabe, Ken-ichi Sako, Yoshihiko Matsuki, Yoshikazu Matsuda, Shigekazu Watanabe, Miki Yajima
Publikováno v:
Japanese Journal of Infection Prevention and Control. 35:22-30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e465ef8fd1e97f0bca708885ddae620
https://doi.org/10.4058/jsei.35.22
https://doi.org/10.4058/jsei.35.22
Autor:
Ken-ichi Sako, Yukio Kato, Yuta Nakamaru, Yoko Ishihara, Sotaro Goto, Yoshikazu Matsuda, Kazuro Ikawa, Tomoji Maeda
Publikováno v:
Therapeutic drug monitoring. 43(4)
Plasma teicoplanin concentrations do not reach the therapeutic range in several patients with hematological malignancies. Nevertheless, the characteristics of the population pharmacokinetic (PPK) models have not been clarified for malignancy. The dec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7040c09fb25479c06611285f2fa7290c
https://pubmed.ncbi.nlm.nih.gov/34250964
https://pubmed.ncbi.nlm.nih.gov/34250964